
| Serial Number | 88549795 | 
| Word Mark | PAINSTIPATION | 
| Filing Date | Tuesday, July 30, 2019 | 
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE | 
| Status Date | Tuesday, June 2, 2020 | 
| Registration Number | 0000000 | 
| Registration Date | NOT AVAILABLE | 
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form | 
| Published for Opposition Date | NOT AVAILABLE | 
| Goods and Services | Providing medical information related to chronic pain due to irritable bowel syndrome with diarrhea, opioid-induced constipation, and ulcerative colitis; Providing medical information about chronic pain due to irritable bowel syndrome with diarrhea, opioid-induced constipation, and ulcerative colitis through websites, patient brochures and convention panels | 
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | 
| US Class Codes | 100, 101 | 
| Class Status Code | 6 - Active | 
| Class Status Date | Saturday, August 10, 2019 | 
| Primary Code | 044 | 
| First Use Anywhere Date | Thursday, April 5, 2018 | 
| First Use In Commerce Date | Thursday, April 5, 2018 | 
| Party Name | Bausch Health Ireland Limited | 
| Party Type | 10 - Original Applicant | 
| Legal Entity Type | 99 - Other | 
| Address | DUBLIN 24 IE  | 
| Event Date | Event Description | 
| Tuesday, October 22, 2019 | NON-FINAL ACTION WRITTEN | 
| Friday, August 2, 2019 | NEW APPLICATION ENTERED | 
| Saturday, August 10, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 
| Tuesday, October 22, 2019 | ASSIGNED TO EXAMINER | 
| Tuesday, June 2, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 
| Tuesday, October 22, 2019 | NON-FINAL ACTION E-MAILED | 
| Tuesday, October 22, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 
| Wednesday, April 16, 2025 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 
| Tuesday, June 2, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |